It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little cont ... Show More
Jul 3
Wake Up, Brush Teeth, Start Day
We all know we should brush and floss our teeth. But the reason goes beyond a sparkling smile and keeping bad breath at bay. The mouth is a critical and often overlooked organ when it comes to improving overall health. Dr. Sanjay Gupta sits down with Dr. Kami Hoss, author of “If ... Show More
31m 8s
Jun 2024
The weight-loss drug revolution
Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show More
17m 28s
Dec 2024
Deep Dive: The Gold Rush to Cure the Obesity Epidemic
<p>GLP-1 weight-loss drugs, such as Novo Nordisk's Ozempic and Eli Lilly's Zepbound, are credited with reversing obesity trends in the U.S. for the first time in decades, according to a new study in the Journal of the American Medical Association. The episode highlights the rapid ... Show More
8m 47s
Aug 2021
Weight loss supplements: how hype triumphs over substance
Weight loss supplements are big business. Fat burners, fat blockers, metabolism boosters, appetite suppressants – these are just some of the popular kinds of pills, potions and herbal concoctions that fly off pharmacy and health food store shelves. But how effective are any of th ... Show More
12m 31s